MicroRNAs in diabetic macroangiopathy.

Cardiovasc Diabetol

Department of Endocrinology and Metabolism, Department of Biotherapy, Center for Diabetes and Metabolism Research, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, 610041, Sichuan, China. ytian@s

Published: September 2024


Article Synopsis

  • Diabetic macroangiopathy is a major cause of diabetes-related deaths globally, influenced by both genetic and environmental factors.
  • MicroRNAs (miRNAs) play significant roles in the development and progression of diabetes and its complications, highlighting their potential as targets for research and treatment.
  • This review focuses on the formation and functions of miRNAs in conditions like atherosclerosis and heart disease, aiming to enhance understanding and innovation in diagnosing and treating diabetic macroangiopathy.

Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Diabetic macroangiopathy is a leading cause of diabetes-related mortality worldwide. Both genetic and environmental factors, through a multitude of underlying molecular mechanisms, contribute to the pathogenesis of diabetic macroangiopathy. MicroRNAs (miRNAs), a class of non-coding RNAs known for their functional diversity and expression specificity, are increasingly recognized for their roles in the initiation and progression of diabetes and diabetic macroangiopathy. In this review, we will describe the biogenesis of miRNAs, and summarize their functions in diabetic macroangiopathy, including atherosclerosis, peripheral artery disease, coronary artery disease, and cerebrovascular disease, which are anticipated to provide new insights into future perspectives of miRNAs in basic, translational and clinical research, ultimately advancing the diagnosis, prevention, and treatment of diabetic macroangiopathy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11406791PMC
http://dx.doi.org/10.1186/s12933-024-02405-wDOI Listing

Publication Analysis

Top Keywords

diabetic macroangiopathy
24
artery disease
8
macroangiopathy
6
diabetic
5
micrornas diabetic
4
macroangiopathy diabetic
4
macroangiopathy leading
4
leading diabetes-related
4
diabetes-related mortality
4
mortality worldwide
4

Similar Publications

Disturbance of gut microbiota in diabetes related macroangiopathy: Evidence from the gut bacteriome and mycobiome.

iScience

July 2025

State Key Laboratory of Southwestern Chinese Medicine Resources, School of Ethnic Medicine and Meishan Hospital, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, P.R. China.

Diabetes related macroangiopathy (DMA) is a major complication of type 2 diabetes (T2D), impacting both morbidity and mortality. This study characterized the gut bacteriome and mycobiome in 179 adults, including 58 with DMA, 71 with T2D, and 50 healthy controls. The gut microbiome of DMA subjects exhibited reduced alpha diversity, and a distinct microbial composition compared with healthy control.

View Article and Find Full Text PDF

[A prospective study of relationship between glycated hemoglobin level and occurrence of diabetes complications in patients with type 2 diabetes mellitus in 11 provinces of China].

Zhonghua Liu Xing Bing Xue Za Zhi

July 2025

Division of Obesity and Metabolic Disease Control and Prevention, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

To investigate the relationship between glycated hemoglobin (HbA1c) level and the occurrence of diabetes complications in patients with type 2 diabetes mellitus in 11 provinces in China. A total of 4 832 patients with type 2 diabetes mellitus from 60 surveillance sites in 11 provinces where national surveillance for chronic diseases and risk factors was conducted in 2010 were selected as the study participants, and a follow-up survey was conducted in 3 516 persons from 2016 to 2017, finally 3 427 patients were included in the analysis after excluding those data exception and incomplete data. Cox proportional risk regression model was used to evalaute the association between HbA1c level and the risk for diabetes complications (macroangiopathy, microangiopathy and diabetic foot), and subgroup analyses were conducted according to the baseline characteristics of the study participants, such as age, gender and smoking status.

View Article and Find Full Text PDF

Hypoglycemia is a commonly neglected complication in elderly diabetic patients, which can lead to cardiovascular events. Endothelial cell dysfunction is the primary inducer of cardiovascular events, and it is associated with hypoglycemia-triggered cytokine release and inflammatory programmed cell death. A comprehensive understanding of lineage-specific variations in pathological vascular changes is essential to mitigate cardiovascular events and ensure therapeutic efficacy.

View Article and Find Full Text PDF

Objective: Isthmin-1 (ISM-1), a novel adipokine, has dual effects of increasing fat and glucose uptake while inhibiting hepatic fat synthesis. However, little literature has been found dealing with ISM-1 levels in type 2 diabetes patients with macroangiopathy. The aim of the study was to evaluate possible relationships between ISM-1 peptide levels and macrovascular (MACV) complications in type 2 diabetic subjects.

View Article and Find Full Text PDF

It has been known since ancient times that garlic (Allium sativum), a member of the Alliaceae family, is an indispensable component of human food. This compound contains abundant nutrients, minerals, sulphur-containing compounds, essential oils, phenols, and free amino acids. Sugar levels in the blood that are abnormally high are a symptom of diabetes mellitus, in which the body has difficulty appropriately regulating glucose metabolism.

View Article and Find Full Text PDF